Committee for Orphan Medicinal Products (COMP): 3-5 November 2021
Date:
03/11/2021 to 05/11/2021
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
COMP meeting report on the review of applications for orphan designation: November 2021 (PDF/176.9 KB)
First published: 10/11/2021
EMA/COMP/639056/2021 -
List item
Agenda - COMP agenda of the 3 - 5 November 2021 meeting (PDF/260.55 KB)
Draft
First published: 29/10/2021
EMA/COMP/576903/2021 -
List item
Minutes of the COMP meeting on 3 - 5 November 2021 (PDF/468.9 KB)
Adopted
First published: 21/01/2022
EMA/COMP/647448/2021